Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs2910164
rs2910164
0.040 GeneticVariation BEFREE No significant association between miR-146a rs2910164G/C polymorphism and gastrointestinal cancer susceptibility was found in this meta-analysis. 25693929

2014

dbSNP: rs2910164
rs2910164
0.040 GeneticVariation BEFREE Case-control or cohort studies about the relationship between miR-146a rs2910164</span> G/C polymorphism and gastrointestinal cancer susceptibility were screened and included in this meta-analysis. 25693929

2014

dbSNP: rs2910164
rs2910164
0.040 GeneticVariation BEFREE This meta-analysis suggests that the miR-146a rs2910164 G > C polymorphism is a low-penetrant risk factor for digestive cancers in Chinese. 23534761

2013

dbSNP: rs2910164
rs2910164
0.040 GeneticVariation BEFREE Lack of association of miR-146a rs2910164 polymorphism with gastrointestinal cancers: evidence from 10206 subjects. 22761848

2012

dbSNP: rs2910164
rs2910164
0.040 GeneticVariation BEFREE Besides, the C allele of the rs2910164 might be associated with a protection from digestive cancer. 21637771

2011

dbSNP: rs2292832
rs2292832
0.030 GeneticVariation BEFREE Mir-149 rs2292832 may modulate the risk of gastrointestinal tract cancers especially colorectal cancer. 30930933

2019

dbSNP: rs2292832
rs2292832
0.030 GeneticVariation BEFREE The present study aimed to investigate the association between two miRNA polymorphisms (miR-499 rs3746444 and miR-149 rs2292832) and gastrointestinal (GI) cancer risk. 24312386

2013

dbSNP: rs2292832
rs2292832
0.030 GeneticVariation BEFREE To explore the associations of SNPs within hsa-miR-605 (rs2043556) and hsa-miR-149 (rs2292832) and lifestyle-related factors with gastrointestinal cancer, a case-control study including 762 cases and 757 controls was conducted. 21976437

2012

dbSNP: rs4938723
rs4938723
0.020 GeneticVariation BEFREE However, in stratified analysis by cancer types, the rs4938723 polymorphism significantly increased the risk of gastrointestinal cancer, hepatocellular carcinoma. 30203457

2019

dbSNP: rs63750447
rs63750447
0.020 GeneticVariation BEFREE MLH1 V384D germline variant may not only contribute to gastrointestinal cancer predisposition but may also contribute to BC in East Asians. 31358837

2019

dbSNP: rs11549465
rs11549465
0.020 GeneticVariation BEFREE Our meta-analysis suggests that HIF-1α rs11549465 C>T and rs11549467 G>A polymorphisms influence the pathogenesis of digestive cancers in Asians. 29578149

2018

dbSNP: rs11549467
rs11549467
0.020 GeneticVariation BEFREE Our meta-analysis suggests that HIF-1α rs11549465 C>T and rs11549467 G>A polymorphisms influence the pathogenesis of digestive cancers in Asians. 29578149

2018

dbSNP: rs920778
rs920778
0.020 GeneticVariation BEFREE SNP rs920778 is also a useful risk factor in evaluation of Asian population and digestive cancer. 27965458

2017

dbSNP: rs920778
rs920778
0.020 GeneticVariation BEFREE However, in further stratified analyses, the variant T allele of rs920778 exhibited a significant increased risk of developing digestive cancers (dominant model: OR = 1.44; 95% CI = 1.31-1.59). 27010768

2016

dbSNP: rs1130409
rs1130409
0.020 GeneticVariation BEFREE The results of this meta-analysis collectively suggest that APE1 gene Asp148Glu variant is not a risk-conferring factor for digestive cancer. 26292623

2015

dbSNP: rs1130409
rs1130409
0.020 GeneticVariation BEFREE This meta-analysis suggests that the APE1 Asp148Glu polymorphism G allele is associated with an increased GI cancer risk, especially in gastric cancer. 25945024

2015

dbSNP: rs4938723
rs4938723
0.020 GeneticVariation BEFREE The current evidence supports the conclusion that the miR-34b/c rs4938723 polymorphism decreases an individual's susceptibility to digestive cancers. 26320502

2015

dbSNP: rs11549465
rs11549465
0.020 GeneticVariation BEFREE To understand the role of HIF-1α P582S and A588T genotypes in digestive cancer development, we conducted a comprehensive meta-analysis involving 1,517 cases and 3,740 controls. 24293391

2014

dbSNP: rs11549467
rs11549467
0.020 GeneticVariation BEFREE To understand the role of HIF-1α P582S and A588T genotypes in digestive cancer development, we conducted a comprehensive meta-analysis involving 1,517 cases and 3,740 controls. 24293391

2014

dbSNP: rs2274223
rs2274223
0.020 GeneticVariation BEFREE In recent years, the PLCE1 rs2274223 polymorphism has been extensively investigated as a potential risk factor for upper gastrointestinal cancers, including squamous cell carcinoma (ESCC) and gastric cancer. 23826241

2013

dbSNP: rs4986790
rs4986790
0.020 GeneticVariation BEFREE Furthermore, the association between rs4986790 and cancer risk was statistically significant in digestive cancers (dominant model: OR = 1.76, 95% CI: 1.13-2.73) and female-specific cancers (dominant model: OR = 1.50, 95% CI: 1.16-1.94). 24376595

2013

dbSNP: rs4986790
rs4986790
0.020 GeneticVariation BEFREE Two recent meta-analyses showed that D299G is associated with inflammatory bowel disease and gastrointestinal cancers risk, two pathological states in which the luminal microbial flora-host cells interaction may be implicated. 23275193

2013

dbSNP: rs2274223
rs2274223
0.020 GeneticVariation BEFREE Recently, two large genome-wide association studies, conducted in Chinese populations, have reported associations between upper gastrointestinal cancer and the rs2274223, rs13042395 and rs4072037 polymorphisms in PLCE1, C20orf54 and MUC1, respectively. 22805490

2012

dbSNP: rs63750447
rs63750447
0.020 GeneticVariation BEFREE The V384D and the Q701K variant resulted in the interaction of hMLH1 with hPMS2 at reduced efficiency and might raise the gastrointestinal cancer risk of the mutation carriers. 18094436

2007

dbSNP: rs11896604
rs11896604
0.010 GeneticVariation BEFREE Rs11125529 under the recessive model (OR = 2.05, 95% CI: 1.00-4.23, p = 0.038), rs843711 in recessive model (OR = 1.37, 95% CI: 1.04-1.82, p = 0.026), and rs11896604 under log-additive model (OR = 1.23, 95% CI: 1.01-1.51, p = 0.042) were associated with an increased risk of GI cancer. 31070019

2019